Deirdrem Mccarthy News Today

/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), an innovative and fully integrated pharmaceutical company with a robust portfolio of approved products for the...

APSARD and Tris Pharma Announce the 2021 Tris Research Award in ADHD News provided by Share this article Share this article MONMOUTH JUNCTION, N.J., Jan. 28, 2021 /PRNewswire/ -- The American Professional Society of ADHD and Related Disorders ("APSARD"), a professional organization focused on improving outcomes for individuals with ADHD and their families, and Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of approved products for the treatment of Attenti...